Curaxys hires five more technologists.
Curaxys hires five more technologists with the support of the Inncorpora Program granted by the Ministry of Economy and Competitiveness. 
One of the largest biopharmaceutical projects in Europe to be started at Tecnobahía.
Curaxys S.L. and Obras Coman S.A. have signed a contract to excecute a Biopharma Plant to produce biological medicines and other recombinant proteins to cure different diseases like cancer.
Curaxys, Agroaxis and Innovaxis has been funded by INNPLANTA 2011, through the Spanish Ministry of Economy and Competitiveness, co-funded by FEDER funds of the EU, “Una manera de hacer Europa”
|
 |
Curaxys: the biopharmaceuticals company focused on production of biosimilars medicines.
We specialize in creating original technologies to develop new biological process useful for the production of therapeutical biological compounds: BIOSIMILARS.
Curaxys is a European biopharmaceutical company specialized in the research, development, production and commercialization of therapeutical proteins of high add technological value thanks to its own technology which allows from the genes translation to the industrial proteins production.
Curaxys activities are focused in the commercialation of generics, biogenerics, and the producton and commercialization of biosimilars and biobetters. In order to achieve these activities Curaxys has pattended three Technological Platforms:
| CuraMab® |
mAb and therapeutic proteins, obtained through mamalian cell culture (CHO y Per.C6®) (PERC6 is a Crucell’s trade mark). |
GreenMab® |
mAb and therapeutic proteins, obtained through vegetable cells, fully humanized. |
XpanCell® |
Developing therapeutical angiogenesis for the treatment of cardiovascular ischemiae using expanded non-embryonic human stem cells. |
We focus on the research, production and commercialization of recombinant proteins through the CHO and Per.C6® cell lines.
|
 |
Our expression system allows us to reach of recombinant protein levels that are clearly above those currently available.
|
|
We developed a downstream technological platform on the basis of our own laboratory data. |
|
Curaxys obtained finance through de Ministry of Science and Innovation, inside the “Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008-2011”, through Inncopora Program 2010, (files INC10-0289, INC10-0290, INC10-0291, INC10-0292)
|  |
|
